Arlington Trust’s AbbVie ABBV Stock Holding History

Arlington Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$520K	Buy	1,988 +838	+73%	+$215K	0.04%	83
2026 Q2	$289K	Buy	1,150 +286	+33%	+$61.5K	0.02%	86
2026 Q1	$188K	Buy	864 +334	+63%	+$74.1K	0.02%	101
2025 Q4	$121K	Sell	530 -5,249	-91%	-$1.2M	0.01%	125
2025 Q3	$1.34M	Hold	5,779	–	–	0.24%	53
2025 Q2	$1.07M	Sell	5,779 -197	-3%	-$36.6K	0.21%	62
2025 Q1	$1.25M	Sell	5,976 -802	-12%	-$156K	0.27%	52
2024 Q4	$1.2M	Buy	6,778 +100	+1%	+$18.4K	0.25%	53
2024 Q3	$1.32M	Buy	6,678 +40	+0.6%	+$7.46K	0.29%	48
2024 Q2	$1.14M	Buy	6,638 +1,588	+31%	+$263K	0.27%	53
2024 Q1	$920K	Sell	5,050 -150	-3%	-$25.9K	0.24%	57
2023 Q4	$806K	Buy	+5,200	New	+$758K	0.23%	62

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Arlington Trust's ABBV Position: Q3 2026 in Review

Arlington Trust increased its AbbVie (ABBV) stake by 73% in Q3 2026, buying an estimated $215K and bringing the position to 1,988 shares worth $520K. The position accounts for 0.04% of the portfolio, ranked #83.

Arlington Trust first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.34M in Q3 2025. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Arlington Trust held 1,988 shares of AbbVie worth $520K as of Q3 2026.
Arlington Trust bought 838 AbbVie shares in Q3 2026, an estimated $215K.
AbbVie made up 0.04% of Arlington Trust's portfolio in Q3 2026, its #83 holding.
Arlington Trust first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
Arlington Trust's AbbVie position peaked at $1.34M in Q3 2025.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.